NeuroGen Brain and Spine Institute

What NeuroGen Brain and Spine Institute does

NeuroGen Brain and Spine Institute (NeuroGen BSI) is a privately held, Navi Mumbai-based specialty medical institute that treats neurological disorders using Autologous Bone Marrow Mononuclear Cells Grafting (ABMMCG), a regenerative procedure in which the patient's own bone marrow tissue is minimally manipulated and grafted in the same surgical sitting. The institute positions itself as the first in the world to establish ABMMCG as a safe and effective treatment for Autism, and additionally treats Muscular Dystrophy, Cerebral Palsy, Intellectual Disability, Spinal Cord Injury, Traumatic Brain Injury, Stroke, Dementia, and Motor Neuron Disease. Its clinical offering is anchored by Director Dr. Alok Sharma and supported by Dr. Nandini Gokulchandran and Dr. Hemangi Sane, with a claimed cumulative caseload of more than 15,000 patients globally.

The institute's core product, ABMMCG, is wrapped in an integrated rehabilitation portfolio of 11 therapy services — including ABA Therapy, Physiotherapy, Occupational Therapy, Aquatic Therapy, Sensory Integration, Speech Therapy, Psychological Intervention, Special Education, Art-based Therapy, Diet Counselling, and Group Therapy — delivered through a multidisciplinary team at the Navi Mumbai facility. A Virtual OPD telemedicine channel and free tele-rehabilitation consultations extend reach to international and remote patients. The institute markets primarily through educational content, blogs, webinars, and patient testimonial videos, and has accumulated over 100 scientific publications, over 10 scientific books, and several international awards including the Rose of Paracelsus Award and the Times Health Excellence Award.

NeuroGen BSI generates revenue from medical treatment services — principally one-time ABMMCG procedures bundled with rehabilitation therapy — for individual patient-consumers rather than enterprise accounts; pricing is not publicly disclosed. The institute operates without disclosed parent company, subsidiary, external investor, or funding round, and appears to be founder-controlled. Distribution is a hybrid of in-person treatment at the single Navi Mumbai facility plus Virtual OPD teleconsultation for remote and international patients across India, the UK, South Africa, and other markets.

Name

NeuroGen Brain and Spine Institute

Legal name

NeuroGen Brain and Spine Institute

Website

https://neurogenbsi.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

NeuroGen Brain and Spine Institute is a Navi Mumbai-based specialty medical institute that treats incurable neurological disorders such as Autism, Cerebral Palsy, Muscular Dystrophy, and Spinal Cord Injury using Autologous Bone Marrow Mononuclear Cells Grafting combined with an integrated multidisciplinary rehabilitation program, serving individual patients in person and via Virtual OPD teleconsultation.

Ownership category

akta.pro rank

Product category

Neurological Treatment Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Other Health Practitioners (6213)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)

akta.pro secondary industries

Spinal Cord Injury Rehabilitation Centers (HLAFAFAM), Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ), Neuromuscular Medicine (ALS, Myasthenia, Neuropathy) (HLAKAIAD), Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH)

Keywords

• Neurological treatment services
• Regenerative medicine therapy
• Autism treatment center
• Cerebral palsy therapy
• Brain and spine institute

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Treatment Services: Revenue generated from providing comprehensive neurological treatment services including the ABMMCG procedure, rehabilitation therapies, and multidisciplinary care for patients with neurological disorders.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

NeuroGen Brain and Spine Institute is a multidisciplinary neurological treatment institute that delivers the Autologous Bone Marrow Mononuclear Cells Grafting (ABMMCG) procedure together with an integrated suite of 11 rehabilitation therapies (ABA Therapy, Physiotherapy, Occupational Therapy, Aquatic Therapy, Sensory Integration, Speech Therapy, Psychological Intervention, Special Education, Art-based Therapy, Diet Counselling, and Group Therapy) to treat incurable neurological conditions such as Autism, Cerebral Palsy, Muscular Dystrophy, Spinal Cord Injury, Traumatic Brain Injury, Stroke, Dementia, and Motor Neuron Diseases. The institute also provides Virtual OPD teleconsultations for remote and international patients.

Product overview

NeuroGen Brain and Spine Institute operates as a multidisciplinary neurological treatment center offering a comprehensive care model centered on Autologous Bone Marrow Mononuclear Cells Grafting (ABMMCG) as its core regenerative medical procedure. The institute complements this with an integrated portfolio of 11 therapeutic services spanning ABA Therapy, Physiotherapy, Occupational Therapy, Aquatic Therapy, Sensory Integration Therapy, Speech Therapy, Psychological Intervention, Special Education, Art-based Therapy, Diet Counselling, and Group Therapy/Motivational Workshops. The ABMMCG procedure provides neurological support while the therapy services function as structured rehabilitation components delivered through a coordinated multidisciplinary team model. The institute also provides Virtual OPD services for remote consultations.

Differentiator

Problem solved

Functional benefit

Products and services

• ABMMCG (Autologous Bone Marrow Mononuclear Cells Grafting) A pioneering regenerative medical procedure involving minimal manipulation of the patient's own bone marrow tissue, grafted during the same surgical sitting, designed to treat incurable neurological disorders including Autism, Cerebral Palsy, Muscular Dystrophy, Spinal Cord Injury, Traumatic Brain Injury, Stroke, Dementia, and Motor Neuron Diseases.
• ABA Therapy (Applied Behavior Analysis) Structured, evidence-based behavioral intervention targeting attention, social turn-taking, repetitive behaviors, and foundational readiness skills for children with autism.
• Physiotherapy Exercise-based sessions aimed at treating muscle tone abnormalities, improving motor movements, posture, balance, strength, and limb coordination in neurological patients.
• Occupational Therapy Therapeutic intervention focusing on hand strength, hand-eye coordination, task planning, daily living skills, and sensory processing for both adult and pediatric clients.
• Aquatic Therapy Water-based therapy utilizing resistance, buoyancy, and sensory input properties to support motor development and sensory regulation in a low-pressure environment.
• Sensory Integration Therapy Therapeutic activities involving movement, touch, and body awareness to help regulate the nervous system's response to sensory experiences.
• Speech Therapy Communication development services addressing verbal language, augmentative and alternative communication (AAC) tools, social communication skills, and speech clarity.
• Psychological Intervention Therapeutic support for emotional and behavioral challenges, helping children manage reactions and develop healthier coping strategies.
• Special Education Individualized learning support using visual aids, adapted teaching methods, and customized learning plans to make education accessible for children with developmental disorders.
• Art-based Therapy Non-verbal therapeutic channel for emotional expression and creativity, building attention, fine motor skills, and task completion for children who struggle with verbal expression.
• Diet Counselling Nutritional guidance addressing gut health, food sensitivities, and digestive issues commonly associated with neurological conditions, supporting overall health and behavioral outcomes.
• Group Therapy/Motivational Workshops Structured peer-environment sessions practicing social skills, communication, turn-taking, and emotional regulation in real-world social interaction contexts.
• Virtual OPD Telemedicine platform offering virtual consultations and video-based medical services, enabling remote patient consultations and follow-ups for international patients and those unable to visit physically, including free tele-rehabilitation consultations.

Quantifiable outcome

• Over 15,000 patients treated globally
• +2 more outcomes

Named customers6 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• StemGenex: US-based clinic offering autologous stem cell treatments for neurological conditions including multiple sclerosis, Parkinson's, and ALS. Comparable as a direct-to-patient regenerative-medicine provider for neurological conditions, though operating from a US base rather than a medical-tourism destination.
• Beike Biotechnology: China-based cell therapy provider offering adult stem cell treatments for a wide range of neurological and chronic conditions. Comparable as a service-oriented cell therapy institute targeting patients with autism, cerebral palsy, spinal cord injury, and similar neurological indications, with similar medical-tourism-oriented business model.
• BrainStorm Cell Therapeutics: Clinical-stage cell therapy company developing autologous stem cell therapies for neurodegenerative diseases including ALS and MS. Comparable as a developer of autologous cell-based treatments for neurological conditions, though operating in a more pharma-like clinical-trial model rather than a service-based treatment institute.
• Hope Biosciences: US-based regenerative medicine company developing autologous cell therapies for neurological and autoimmune conditions. Comparable as a provider of cell-based treatments targeting neurological disorders, with overlapping technology philosophy though operating in a clinical-trial and therapeutic-development model rather than direct-to-patient treatment institute.

Broad incumbents

• Fortis Healthcare: Major Indian hospital chain with neurology, neurosurgery, and rehabilitation departments across multiple cities. Comparable in targeting patients with neurological conditions in India and competing for medical-tourism revenue, but operates as a broad multi-specialty provider rather than a neurological specialist.
• Apollo Hospitals: India's largest hospital chain with established neurology and neurosurgery programs across multiple cities. Comparable as a competing destination for patients seeking neurological care in India and for inbound medical tourists, with deeper capital and brand recognition though less specialization in regenerative cell therapy.
• Medanta - The Medicity: Large multi-specialty Indian hospital chain with a strong neurosciences institute offering treatment for spinal cord injury, stroke, and other neurological conditions. Comparable because it competes for the same pool of neurology patients in India, particularly those considering international options, but operates at much broader scale and lacks NeuroGen's specialized cell-therapy focus.
• Manipal Hospitals: Major Indian hospital chain with multi-specialty neurology and rehabilitation services across multiple cities. Comparable in competing for Indian neurology patients and medical-tourism flows, with deeper geographic footprint though less specialization in regenerative cell therapy.
• Narayana Health: Large Indian hospital network with strong neurology and cardiac sciences specialties serving both domestic and international patients. Comparable as a competing destination for specialty medical tourism in India, though operating across broader specialties rather than a focused neurological institute.

Emerging players

• Q Therapeutics: Cell therapy developer focused on neurological disease applications using cell-based approaches. Comparable as a developer of cell therapies for neurological conditions, though at an earlier development stage and operating in a research/clinical-trial model rather than as a treatment institute.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/neurogenbsi
• Facebookfacebook.com/NeuroGenBSI

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroGen Brain and Spine Institute